Accolade Inc
NASDAQ:ACCD
Accolade Inc
EPS (Diluted)
Accolade Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
EPS (Diluted)
-$6
|
CAGR 3-Years
-81%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
EPS (Diluted)
$7
|
CAGR 3-Years
6%
|
CAGR 5-Years
52%
|
CAGR 10-Years
10%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
EPS (Diluted)
$5
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Cigna Corp
NYSE:CI
|
EPS (Diluted)
$17
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
EPS (Diluted)
$5
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-2%
|
See Also
What is Accolade Inc's EPS (Diluted)?
EPS (Diluted)
-6.5
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's EPS (Diluted) amounts to -6.5 USD.
What is Accolade Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-38%
Over the last year, the EPS (Diluted) growth was -234%. The average annual EPS (Diluted) growth rates for Accolade Inc have been -81% over the past three years , -38% over the past five years .